Dr.Reddy's |

Dr. Reddy’s is an integrated pharmaceutical firm that focuses on global generics and pharmaceutical products and services.

What section would you like to update?
  • Company Logo
  • Company Name & URL
  • Company Description
  • Founded Date
  • Company Status
  • HQ Address
  • Social Links
  • CEO Name & Picture
  • Competitor Set
  • Funding Events
  • Acquisition Events

If you'd like to make any changes to this portfolio we'd be happy to help. Please send info/sources to support@owler.com.


We'll be back up as soon as possible.

Visit owler.uservoice.com for FAQs

Dr.Reddy's Revenue, Funding, Number of Employees, Competitors and Acquisitions

DR.REDDY'S CEO

G V Prasad

CEO

G V Prasad

Approval Rating: 76/100

WEIGH-IN

How would you rate G V Prasad as a CEO?

negative
You
neutral
You
positive
You

Founded:

1984

Headquarters:

HyderabadAndhra Pradesh

Status:

PublicNYSERDY

Industry Sector:

- -

Completeness:

100%

KEY STATS

Revenue

- -

What is Dr.Reddy's's revenue?

<1M

Employees

- -

How many people work at Dr.Reddy's?

Followers on Owler

- -

FOLLOW
UNFOLLOW

TOP COMPETITORS

Add a new competitor:

Thanks for your contribution!

Recalculating The Competitive Graph now...

ADD

Dr.Reddy's was founded in 1984 and its headquarters is located in Hyderabad, Andhra Pradesh, IN. Dr.Reddy's has $2.2B in revenue and 22671 employees. Dr.Reddy's' top competitors are Lupin Pharmaceuticals, Sun Pharma and Zydus.

Dr.Reddy's Competitive Set

COMPANYLEADERSHIPCEO SCORE

EMPLOYEES
(ESTIMATED IF PRIVATE)

TOTAL FUNDING

REVENUE
(ESTIMATED IF PRIVATE)

LIKELY OUTCOME
Dr.Reddy'sDr.Reddy's ceo

G V Prasad

CEO

76/100
1Lupin Pharmaceuticals ceoLupin Pharmaceuticals

Vinita Gupta

CEO

68/100
$2B
2Sun Pharma ceoSun Pharma

Dilip S. Shanghvi

Managing Director

68/10030,000
$4.4B
3Zydus ceoZydus

Pankaj R. Patel

Managing Director

77/10012,227
$54.7B
4Glenmark ceoGlenmark

Glenn Saldanha

CEO

85/1007,000
$824.9M
5Aurobindo Pharma ceoAurobindo Pharma

Govindarajan Narayanan

Managing Director

74/10013,288
$1.6B
6Cadila Pharmaceuticals ceoCadila Pharmaceuticals

Dr. Rajiv I. Modi

Managing Director

50/100
$100M
7Reliance Life Sciences ceoReliance Life Sciences

K.V. Subramaniam

President & CEO

84/100
$10M
8Serum Institute of India ceoSerum Institute of India

Adar C. Poonawalla

CEO

56/100200

Dr.Reddy's Revenue History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

$

Community Estimate

UPDATE THIS

Dr.Reddy's Employee History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

Community Estimate

UPDATE THIS

Dr.Reddy's Leadership

NAMETITLESOCIAL MEDIA
G V Prasad
G V Prasad

CEO

CEO

Dr.Reddy's Acquisitions

COMPANY ACQUIRED ACQUISITION DATEAMOUNTDESCRIPTION
undefinedMar 2017306.6K

Dr.Reddy's' latest acquisition was in Mar 2017.

Dr.Reddy's News

Dr.Reddy's: Dr Reddy's arm to defend against charges in US lawsuitHyderabad: Dr Reddy's Laboratories Inc, the US subsidiary of the Indian drug major, on Monday said it would defend against allegations made in a US securities class action lawsuit by a law firm on behalf of some investors."As intimated earlier, we believe that the asserted claims are without merit and we intend to vigourously defend against the allegations," the city-based parent firm said in a regulatory filing on the BSE.The drug maker also said that the law firm (lead plaintiff) had added its Chairman Satish Reddy, Chief Operating Officer Abhijit Mukherjee and its US arm as defendants in the amended complaint.The lawsuit was filed in August 2017 against the subsidiary in the US District Court for New Jersey, alleging violation of the US federal securities laws.The lawsuit was served in November by the plaintiff, representing investors who bought its shares on the New York Stock Exchange between June 2015 and August 2017.The company has been accused of making false or misleading statements about its corporate quality system.Samachar
Dr.Reddy's: DRL chairman, COO added as defendants in US suitDr Reddy's Laboratories (DRL) on Monday said its chairman Satish Reddy, COO Abhijit Mukherjee and US subsidiary have been included as defendants in the class action lawsuit filed against it by investors.The Financial Express
Dr.Reddy's: Dr Reddy#39;s Chairman, COO added as defendants in US lawsuitLast year in August, the company had said "a law firm representing a purported investor in the company filed a purported class action lawsuit against the company, its CEO and CFO in the US District Court for the District of New Jersey alleging violation of the US federal securities laws."Moneycontrol
Dr.Reddy's: Indian pharma firms renew focus; Dr Reddy's, Cipla eye $100-bn China marketDRL looking to introduce anti-cancer drugs, while Cipla, Wockhardt planning to launch core therapiesBusiness Standard
Dr.Reddy's: Dr Reddy's Laboratories recalls over 80,000 bottles of Atorvastatin from USDr Reddy's Laboratories has initiated voluntary recall of over 80,000 bottles of Atorvastatin calcium tablets of 10mg, 20mg and 40mg from the US market due to quality concerns.The Financial Express
Dr.Reddy's: Indivior files lawsuit against Dr Reddy's for infringing on US patentsUK-based Indivior on Thursday said its US unit Indivior has filed lawsuits against Dr Reddy's Laboratories, Actavis Generics, Par Pharmaceutical, Alvogen Pharmaceutical and Teva Pharmaceutical Industries for infringing on US patents for the company's Suboxone sublingual film product.The Financial Express
Dr.Reddy's: FM#39;s universal healthcare proposal a step in right direction: DRLIn an exclusive conversation with CNBC-TV18#39;s Nitya Balakrishnan, Saumen Chakraborty of DRL adds that the company will maintain its capex target of Rs 1,000 crore for FY19, and it will focus on biological research and development (RD).moneycontrol
Dr.Reddy's: Dr Reddy's Labs acquiring products but not marketing most of themIn 5 of 9 asset buys made in 2014-16, Dr Reddy's is yet to put them to use; it spent Rs 38.82 bn on the acquisitionsBusiness Standard
Dr.Reddy's: Dr.Reddy's Laboratories and Aurobindo Pharma are no longer in contention for Orchid Pharma, the report said.Dr.Reddy’s Laboratories and Aurobindo Pharma are no longer in contention for Orchid Pharma, the report said.VCCircle
Dr.Reddy's: Dr Reddy#39;s launches generic Tetrabenazine tablets in USThe company#39;s Tetrabenazine tablets have been approved by the United States Food and Drug Administration (USFDA), Dr Reddy#39;s Laboratories said in a filing to the BSE. They are a generic version of Valeant Pharmaceuticals Luxembourg S A R L#39;s Xenazine tablets, it added.moneycontrol

SEE MORE

SEE LESS

Dr.Reddy's Website History

Screengrabs of how the Dr.Reddy's site has evloved. (Click to expand)

Dr.Reddy's website history

Aug 2017

Dr.Reddy's website history

Jun 2017

Dr.Reddy's website history

Feb 2017

Dr.Reddy's website history

Nov 2016

Dr.Reddy's website history

Aug 2016

Dr.Reddy's website history

May 2016

Dr.Reddy's website history

Feb 2016

Dr.Reddy's website history

Nov 2015

Dr.Reddy's website history

Aug 2015

Dr.Reddy's website history

May 2015

Dr.Reddy's website history

Feb 2015

Dr.Reddy's website history

Nov 2014

Dr.Reddy's website history

Aug 2014

Dr.Reddy's website history

May 2014

Owler has collected 14 screenshots of Dr.Reddy's' website since May 2014. The latest Dr.Reddy's website design screenshot was captured in Aug 2017.

Dr.Reddy's Headquarters

undefined company logo

8-2-337, Road No. 3 Banjara Hills

Hyderabad, Andhra Pradesh 500 034

91-40-49002900

Driving Directions

google map

Dr.Reddy's Summary Information

Dr. Reddy’s is an integrated pharmaceutical firm that focuses on global generics and pharmaceutical products and services. Dr.Reddy's was founded in 1984. Dr.Reddy's' headquarters is located in Hyderabad, Andhra Pradesh, IN 500 034. Dr.Reddy's' latest acquisition was . Dr.Reddy's' CEO, G V Prasad, currently has an approval rating of 76%. 72% of Owler community believes the stock will go Up. Dr.Reddy's has 22671 employees and reported 2.2B in revenue [trailing four quarters].

Dr.Reddy's's CEO, G V Prasad, currently has an approval rating of 76%. Dr.Reddy's's primary competitors are  Lupin Pharmaceuticals Sun Pharma Zydus.

Visit the Dr.Reddy's website to learn more.